Smita Annie Maliekal

Director Of Regulatory Affairs at Immunovant

Smita Annie Maliekal is an experienced professional in the regulatory affairs sector, currently serving as the Director of Regulatory Affairs at Immunovant since December 2020, following a role as Associate Director of Regulatory Affairs Operations. Prior experience includes positions as a RIM Business Analyst at Orion Innovation for Bristol-Myers Squibb, and Sr. Manager of RIM Business Process at Amicus Therapeutics. Smita has held significant roles at Daiichi Sankyo, Bristol-Myers Squibb, and various other companies, focusing on regulatory affairs, document management systems, and technical analysis. Smita holds a Master of Science in Computer Engineering from Wright State University and a Bachelor of Engineering from Poona University.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Immunovant

6 followers

Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.


Industries

Employees

51-200

Links